1 citations
,
January 2024 in “Journal of clinical medicine” This literature review highlights the changing epidemiology of tinea capitis due to global migration and underscores the importance of early recognition and treatment of atypical variants in immunocompetent children to minimize prolonged systemic antifungal therapy and prevent adverse events, especially regarding liver health.
10 citations
,
June 2018 in “Aaps Pharmscitech” The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.
August 2022 in “Journal of The European Academy of Dermatology and Venereology” 7 citations
,
May 2021 in “Clinical Case Reports” This abstract discusses Alopecic and aseptic nodule of the scalp as a rare alopecia condition that may be underdiagnosed and reports doxycycline as a safe and effective treatment option.
12 citations
,
December 2018 in “Clinical Ophthalmology” This review summarizes clinical trials and comparative studies showing that latanoprostene bunod 0.024% is effective and safe for reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension, detailing its mechanism and side effects while considering its therapeutic role.
September 2015 in “British Journal of Dermatology” Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.
19 citations
,
September 2002 in “Acta dermato-venereologica” In this retrospective study, anti-tuberculous agents, likely rifampicin, were effective adjunctive therapies for a chalazion, coinciding with spontaneous drainage in a patient with rosacea.
In this case report, a 65-year-old woman with lichen planopilaris achieved stabilization of her condition through early recognition and systemic corticosteroid therapy, emphasizing the critical role of coordinated management between primary care and dermatology.
2 citations
,
April 2015 in “Dermatology practical & conceptual” This case report suggests that regular use of antifungal shampoo might obscure clinical indicators of Trichophyton tonsurans tinea capitis in healthy adults, necessitating detailed diagnostic approaches like histopathology and dermoscopy.
9 citations
,
September 2010 in “Dermatologic therapy” This study found that combined therapy with cetirizine and topical steroids stabilized inflammation in most patients with lichen planus pilaris, though one patient experienced cardiac arrhythmia.
2 citations
,
January 2013 in “Journal of cosmetics, dermatological sciences and applications” This study found that both an anti-dandruff shampoo containing piroctone olamine and climbazole and its combination with a tonic reduced dandruff and inflammation, with the combination showing superior results.
21 citations
,
January 2015 in “Dermatologic Therapy” This letter discusses a case of erosive pustular dermatosis of the scalp linked to topical latanoprost use for androgenetic alopecia, but reports no clinical results.
9 citations
,
October 2020 in “Journal of The American Academy of Dermatology” This letter discusses the limited adaptation of low dose oral minoxidil for androgenetic alopecia in North America and reports no new clinical results; the authors suggest safety concerns or unclear dosing may be factors.
October 2022 in “Gadua Journal of Pure and Allied Science” In this study, Trichophyton tonsurans and Microsporum canis were identified as the primary causes of tinea capitis, with terbinafine treatment showing the highest cure rate. Non-commercial kits surpassed real-time PCR commercial kits in specificity and sensitivity for diagnosis.
November 2023 in “Journal of medical and health studies” In this study, combining low-level laser therapy with microneedling showed statistically significant improvement in hair growth for three adult patients with androgenetic alopecia over three months, suggesting it may be a promising management approach.
June 2025 in “Archives of Dermatological Research” 2 citations
,
January 2017 in “Indian dermatology online journal” This case study reports a 30-year-old woman with a mixed infection of white piedra and pediculosis capitis, indicating the difficulty in distinguishing between these conditions upon casual examination.
In this study, a hair lotion made from Ganoderma lucidum spore extract resulted in new hair follicle growth and improved hair health in both mice and human participants, with 99% acceptance among users, suggesting potential usefulness for treating alopecia.
October 2025 in “Journal of the Endocrine Society” In this case study, a 69-year-old woman with severe hypercortisolism developed acute adrenal insufficiency after starting ketoconazole treatment, highlighting the need for cautious dosing and close monitoring of adrenal function, particularly in patients with prior glucocorticoid exposure.
39 citations
,
April 2001 in “Journal of The American Academy of Dermatology” This article reviews the side effects of topical latanoprost therapy, particularly the hypertrichosis and pigmentation changes of eyelashes and nearby skin, and reports no new clinical results.
February 2022 in “Scientia Pharmaceutica” This study validated that six out of seven tested topical formulations for alopecia are compatible for 6-month use, suggesting they may be practical for compounding pharmacies.
February 2025 in “Prospects in Pharmaceutical Sciences” This source reports that clascoterone cream, a topical androgen receptor inhibitor, has shown effectiveness in treating facial acne vulgaris in patients 12 and older, with clinical trials indicating a favorable safety profile compared to systemic treatments, and potential for broader dermatological applications.
September 2023 in “Journal of The American Academy of Dermatology” This review evaluates the clinical experience of using low-dose oral minoxidil for treating alopecia and highlights the ongoing concerns about its potential side effects without reporting new clinical results.
8 citations
,
September 2023 in “Advanced Pharmaceutical Bulletin” In a double-blind clinical trial, this study found that a gel containing chitosan-coated spironolactone nanoparticles effectively reduced acne lesions over 8 weeks without adverse skin effects, suggesting potential for enhanced acne treatment through targeted skin delivery.
10 citations
,
October 2018 in “Dermatologic Therapy” In this study, researchers tested lotions containing DGLA, S-equol, and propionyl-l-carnitine on individuals with androgenic alopecia, noting a significant increase in hair count for women and a marginal increase for men after 6 months, along with improved hair cycle dynamics.
2 citations
,
August 2021 in “Skin appendage disorders” This case report describes a successful treatment of scalp hair white piedra caused by T. ovoides with oral itraconazole and topical ketoconazole, using a combination of clinical, trichoscopic, microbiologic, and molecular methods for diagnosis.
2 citations
,
July 1996 in “Annals of Internal Medicine” This letter argues that the association between fluconazole therapy and alopecia may be misattributed, suggesting instead that systemic fungal infections themselves could lead to hair loss.
9 citations
,
December 2010 in “Journal of The European Academy of Dermatology and Venereology” This letter reports repigmentation of hair in patients receiving latanoprost therapy.
This case study reports an unusual presentation of erosive lichen planus of the scalp linked to hepatitis C in a patient, highlighting challenges in establishing a definitive correlation between the two conditions.
January 2022 in “Drug Delivery” This study investigated a finasteride and oregano oil-loaded nano-cubosome gel formulation, finding it enhanced drug release and skin permeation and demonstrated synergistic antibacterial effects, suggesting potential for treating alopecia areata.